Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study

Habib A. Ali, Sacconi Sabrina, Giovanni Antonini, Cortés-Vicente Elena, Grosskreutz Julian, Mahuwala K. Zabeen, Mantegazza Renato, Pascuzzi M. Robert, Utsugisawa Kimiaki, Vissing John, Vu Tuan, Wiendl Heinz, Boehnlein Marion, Greve Bernhard, Woltering Franz, Bril Vera
Generalized Myasthenia
Gravis
<p>Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study</p>